glucose, (beta-d)-isomer has been researched along with cdw17 antigen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dongari-Bagtzoglou, A; Li, L | 1 |
Chrysafi, P; Feigh, M; Mantzoros, CS; Perakakis, N; Veidal, SS | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and cdw17 antigen
Article | Year |
---|---|
Epithelial GM-CSF induction by Candida glabrata.
Topics: Antibodies; Antigens, CD; beta-Glucans; Candida glabrata; Cell Line; Cell Line, Tumor; Cytochalasin D; Endocytosis; Epithelial Cells; Glucans; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lactosylceramides; Mouth Mucosa; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Polysaccharides; Polysaccharides, Bacterial; Toll-Like Receptor 4; Zymosan | 2009 |
Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH.
Topics: Animals; Antigens, CD; Benzhydryl Compounds; Biopsy; Body Composition; Body Weight; Disease Models, Animal; Glucose; Glucosides; Homeostasis; Insulin Resistance; Lactosylceramides; Lipidomics; Liver; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Triglycerides | 2021 |